UCDCCC NCTN U10 Program
UCDCCC NCTN U10 Program
批准号:
9128209
负责人:
DAVID R GANDARA
金额:
$9.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-14 至 2016-02-29
关键词:
AddressAmerican College of Radiology Imaging NetworkAmerican College of Surgeons Oncology GroupAreaAwarenessBasic ScienceBiometryCaliforniaCancer CenterCancer ControlCancer PatientCatchment AreaCenter for Translational Science ActivitiesClinicalClinical InvestigatorClinical Nursing ResearchClinical ResearchClinical TrialsCoalCollaborationsCommunitiesComprehensive Cancer CenterEnsureFacultyFundingGenomicsGoalsGynecologic Oncology GroupHealthHumanImageInterventionLaboratoriesLeadLeadershipLinkMalignant NeoplasmsMedical OncologyMinorityMissionMolecular BiologyNational Cancer InstituteNational Clinical Trials NetworkPathologyPatientsPerformancePlayPopulationPrincipal InvestigatorRadiation OncologyRadiation Therapy Oncology GroupRadiology SpecialtyResearch ActivityResearch InfrastructureResearch PersonnelResearch SupportResourcesRoleRuralSchoolsSiteSouthwest Oncology GroupStructureSurgical SpecialtiesThe Jackson LaboratoryTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVeterinary MedicineXenograft procedureacronymsbasecancer carecancer preventioncareer developmentcomparativedesignexperienceimprovedinnovationlaboratory facilitymedical specialtiesmultidisciplinaryoncology programoutreachpatient populationprogramsresearch studytertiary caretumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As the only NCI-designated cancer center for inland Northern California's approximately 6 million people, the UC Davis Comprehensive Cancer Center (UCDCCC) provides both primary cancer cares to a large and growing population, and serves as the tertiary referral center for specialty cancer care for the region. For this applicatin to become a NCTN Network Lead Academic Participating Site, led by Drs. David R Gandara, MD, and Richard K Valicenti, MD UCDCCC will leverage an already established multidisciplinary team of cancer investigators from medical oncology, radiation oncology, surgical specialties, molecular biology/genomics, pathology, radiology, biostatistics, research nursing, and clinical research support to provide clinical trials expertise, scientific and administrative leadership and accrual in NCTN studies across a broad range of tumor types and throughout the cooperative group network. UCDCCC and its faculty have a long-standing and proven track record of impactful contribution to national cooperative group activities, including SWOG, RTOG, GOG, ACRIN, and ACOSOG, as well as to other NCI-related committees and initiatives. Expanding this effort to the NCTN concept will increase both the scope and reach of participation, including integrating additional researchers and providing career development opportunities for new faculty and junior investigators. Continuing a strong track record in cooperative group translational and clinical research leadership, UCDCCC is poised to exploit unique institutional strengths in serving as a laboratory resource for cooperative group trials and
contributing to hypothesis-driven clinical research. Based on over two decades of already serving as the clinical trials "hub" for accrual to NCI-sponsored studies throughout North-Central California, expansion to the NCTN creates a number of additional opportunities for UCDCCC to both increase main site accrual and to extend access to NCTN trials into the community through the UCDCCC Cancer Care Network and affiliate site, which includes substantial underserved, rural and minority patient populations. In summary, UCDCCC represents an interdisciplinary organizational and leadership structure linked to a clinical trials program that will achieve the coals of the NCTN and ensure robust accrual.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UCDCCC NCTN UG1 PROGRAM
-
批准号:9888340
-
项目类别:
-
资助金额:$52.16万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN UG1 PROGRAM
-
批准号:10357788
-
项目类别:
-
资助金额:$55.73万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN UG1 PROGRAM
-
批准号:10584617
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2019
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN U10 Program
-
批准号:8838065
-
项目类别:
-
资助金额:$63.02万
-
财政年份:2014
-
负责人:DAVID R GANDARA
-
依托单位:
UCDCCC NCTN U10 Program
-
批准号:8605734
-
项目类别:
-
资助金额:$70.03万
-
财政年份:2014
-
负责人:DAVID R GANDARA
-
依托单位:
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8352517
-
项目类别:
-
资助金额:$46.96万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8845057
-
项目类别:
-
资助金额:$98.77万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:9038815
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8499157
-
项目类别:
-
资助金额:$109.1万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:8737143
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2011
-
负责人:DAVID R GANDARA
-
依托单位:--
Early Therapeutics Development with Phase II Emphasis
-
批准号:8014373
-
项目类别:
-
资助金额:$14.68万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
Early Therapeutics Development with Phase II Emphasis
-
批准号:8328531
-
项目类别:
-
资助金额:$90.79万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8155
-
批准号:7933254
-
项目类别:
-
资助金额:$94.25万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
-
批准号:7543356
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:--
Early Therapeutics Development with Phase II Emphasis
-
批准号:7789081
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2006
-
负责人:DAVID R GANDARA
-
依托单位:
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
-
批准号:6848158
-
项目类别:
-
资助金额:$10.88万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE III TRIAL OF CISPLATIN & IRINOTECAN VS CISPLATIN & ETOPOSIDE IN PATIENTS W
-
批准号:6975644
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE I TRIAL OF E7389 (HALICHONDRIN B ANALOG)IN PATIENTS WITH ADVANCEDSOLID TUM
-
批准号:6975646
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
DOCETAXEL FOR METASTATIC BREAST CANCER IN PATIENTS AGED 70 YEARS & OLDER (& YOUN
-
批准号:6975645
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
PHASE I STUDY OF STI571 IN PATIENTS WITH MALIGNANCIES & VARYING DEGREES OF LIV
-
批准号:6975647
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2004
-
负责人:DAVID R GANDARA
-
依托单位:
海外基金